In an adult patient over 65 years old with comorbidities who has pneumonia, how many days should amoxicillin‑clavulanate (Augmentin) and azithromycin be given?

Duration of Augmentin and Azithromycin for Pneumonia in Adults >65 with Comorbidities

For adults over 65 with comorbidities and community-acquired pneumonia treated with amoxicillin-clavulanate (Augmentin) plus azithromycin, treat for a minimum of 5 days if clinically stable by day 5, or 7 days for uncomplicated cases without early stability. 1

Treatment Duration Algorithm

The 2019 IDSA/ATS guidelines establish the framework for outpatient pneumonia treatment in this population but do not specify exact duration for combination therapy 1. However, recent evidence provides clear guidance:

For Patients Achieving Clinical Stability:

Clinical stability criteria (all must be met):

• Temperature ≤37°C
• Heart rate ≤100/min
• Respiratory rate ≤24/min
• Systolic BP ≥90 mmHg
• Oxygen saturation ≥90% on room air

Duration based on stability timing:

• 3 days if clinically stable by day 3 2
• 5 days if clinically stable by day 5 2
• 7 days for uncomplicated CAP without early stability 2

Important Caveat for Elderly Patients:

In patients ≥75 years old, only 52% achieve clinical stability by day 5 3. This means most elderly patients with comorbidities will require 7 days of treatment rather than shorter courses. The median treatment duration in this population is 9 days 3.

Specific Antibiotic Dosing

Per IDSA/ATS guidelines for outpatients with comorbidities 1:

Amoxicillin-clavulanate options:

• 500/125 mg three times daily, OR
• 875/125 mg twice daily, OR
• 2000/125 mg twice daily

PLUS

Azithromycin:

• 500 mg on day 1, then 250 mg daily

Evidence Supporting Shorter Durations

Multiple studies demonstrate 3-day azithromycin courses are non-inferior to 7-10 day courses of amoxicillin-clavulanate for community-acquired pneumonia 4, 5, 6. Clinical success rates were 92.6% for 3-day azithromycin versus 93.1% for 7-day amoxicillin-clavulanate 4.

However, these studies primarily enrolled younger, healthier patients. The combination therapy recommended for your patient population (elderly with comorbidities) requires both agents simultaneously, not azithromycin alone.

Critical Clinical Pitfalls

1. Don't automatically stop at 5 days in elderly patients - Most will not meet stability criteria and require 7+ days 3

2. Assess stability criteria daily - This determines when you can safely stop, not an arbitrary day count 2

3. Extend beyond 7 days only for complications - Empyema, bacteremia, or clinical deterioration warrant longer treatment 2

4. Regional resistance matters - The guidelines note macrolide monotherapy is only acceptable where pneumococcal macrolide resistance is <25% 1, which is why combination therapy is recommended for your patient

Practical Approach

Start with a 7-day prescription for both antibiotics in elderly patients with comorbidities. Reassess at day 5:

• If all stability criteria met → can stop at day 5
• If improving but not fully stable → complete 7 days
• If worsening or complicated → extend duration and consider hospitalization

This approach balances antibiotic stewardship with the reality that elderly patients with comorbidities typically need longer courses than younger, healthier adults.